Search research articles
Contact Us
Filters
Showing results (61-70 of 157) with videos related to
Page
of 16
Sort By:
The American Journal of Gastroenterology
|
January 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study
John David Chetwood, Yanna Ko, Aviv Pudipeddi, et al.
Inflammatory Bowel Diseases
|
June 17, 2022
Managing Inflammatory Bowel Disease in Pregnancy: Health Care Professionals' Involvement, Knowledge, and Decision Making
Eleanor Liu, Robyn Laube, Rupert W Leong, et al.
Expert Opinion on Biological Therapy
|
April 18, 2023
Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia
Emilia Anderson, Karen Waller, Aravind Gokul Tamilarasan, et al.
Canadian Journal of Gastroenterology & Hepatology
|
September 20, 2022
Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease
Eva Zhang, Arun Gupta, Aysha Al-Ani, et al.
World Journal of Gastroenterology
|
December 31, 2019
Epidemiology of inflammatory bowel disease in South America: A systematic review
Sriharan Selvaratnam, Santiago Gullino, Lisa Shim, et al.
Msystems
|
February 3, 2021
Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection
Craig Haifer, Sudarshan Paramsothy, Thomas J Borody, et al.
Crohn'S & Colitis 360
|
January 6, 2025
Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on Vedolizumab
Thanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, et al.
BMC Gastroenterology
|
December 19, 2013
Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series
Muhammad W Fazal, Matt P Doogue, Rupert W Leong, et al.
Inflammatory Bowel Diseases
|
December 3, 2025
The Risk of Relapse Associated With Discontinuation of 5-Aminosalicylates in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Arteen Arzivian, David T Rubin, Cynthia H Seow, et al.
Journal of Gastroenterology and Hepatology
|
July 15, 2017
Oral and upper gastrointestinal Crohn's disease
Robyn Laube, Ken Liu, Mark Schifter, et al.
Page
of 16
Search research articles
Search
Showing results (61-70 of 157) with videos related to
Sort By:
Page
of 16
The American Journal of Gastroenterology
|
January 26, 2024
Biological Agents in the Treatment of Crohn's Disease: A Propensity Score-Matched Analysis From the Prospective Persistence Australian National IBD Cohort (PANIC3) Study
John David Chetwood, Yanna Ko, Aviv Pudipeddi, et al.
Inflammatory Bowel Diseases
|
June 17, 2022
Managing Inflammatory Bowel Disease in Pregnancy: Health Care Professionals' Involvement, Knowledge, and Decision Making
Eleanor Liu, Robyn Laube, Rupert W Leong, et al.
Expert Opinion on Biological Therapy
|
April 18, 2023
Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia
Emilia Anderson, Karen Waller, Aravind Gokul Tamilarasan, et al.
Canadian Journal of Gastroenterology & Hepatology
|
September 20, 2022
Misconceptions Drive COVID-19 Vaccine Hesistancy in Individuals with Inflammatory Bowel Disease
Eva Zhang, Arun Gupta, Aysha Al-Ani, et al.
World Journal of Gastroenterology
|
December 31, 2019
Epidemiology of inflammatory bowel disease in South America: A systematic review
Sriharan Selvaratnam, Santiago Gullino, Lisa Shim, et al.
Msystems
|
February 3, 2021
Long-Term Bacterial and Fungal Dynamics following Oral Lyophilized Fecal Microbiota Transplantation in Clostridioides difficile Infection
Craig Haifer, Sudarshan Paramsothy, Thomas J Borody, et al.
Crohn'S & Colitis 360
|
January 6, 2025
Development and Validation of a Scoring System to Predict 2-Year Clinical Remission in Ulcerative Colitis Patients on Vedolizumab
Thanaboon Chaemsupaphan, Aviv Pudipeddi, Huiyu Lin, et al.
BMC Gastroenterology
|
December 19, 2013
Allopurinol use in pregnancy in three women with inflammatory bowel disease: safety and outcomes: a case series
Muhammad W Fazal, Matt P Doogue, Rupert W Leong, et al.
Inflammatory Bowel Diseases
|
December 3, 2025
The Risk of Relapse Associated With Discontinuation of 5-Aminosalicylates in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis
Arteen Arzivian, David T Rubin, Cynthia H Seow, et al.
Journal of Gastroenterology and Hepatology
|
July 15, 2017
Oral and upper gastrointestinal Crohn's disease
Robyn Laube, Ken Liu, Mark Schifter, et al.
Page
of 16